Partner David Rosen was quoted in an Inside Health Policy article on January 22, 2014 titled “Generic Drug Industry Prioritizes Challenge to New Labeling Rule in 2014.” The article discusses the top priority for the generic drug industry in 2014 which will be combating a new regulation aimed at requiring generic drugmakers to make labeling changes to reflect new safety information. Rosen was quoted saying, “I think it’s going to be a pretty big deal.”
People
Related News
June 23, 2025
In the News
Thomas Ferrante Shares Insight on Compliance Considerations for Remote Patient Monitoring
June 20, 2025
In the News
Brian Wheeler and Lyman Thai Comment on Private Equity's Entry into Niche Sports
Foley & Lardner LLP partners Brian Wheeler and Lyman Thai described private equity's growing investments in niche sports in the Pensions & Investments article, "Ares Management buys minority stake in French sailing team."
June 17, 2025
In the News
JillAllison Opell and Jonathan Goeringer Author Article on Legal Risks of Insurance Referral Fees
Foley & Lardner LLP partners JillAllison Opell and Jonathan Goeringer authored the New York Law Journal article, "Is Your Referral Fee Just a Disguised Commission?"